Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Acer Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Acer Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Aselage Steve | Director | 0 | Nov 20, 2023 | 0 |
| Dunn John Michael | Director | 0 | Nov 20, 2023 | 0 |
| Joseph Donald | See Remarks | 0 | Nov 20, 2023 | 0 |
| Palmin Harry S | CHIEF FINANCIAL OFFICER | 0 | Nov 20, 2023 | 0 |
| Schelling Chris | PRESIDENT AND CEO | 0 | Nov 20, 2023 | 0 |
| Davis Jefferson E | CHIEF BUSINESS OFFICER | 0 | Nov 20, 2023 | 0 |
| Griffin Michelle Renee | Director | – | Mar 16, 2023 | 0 |
| Amello Jason | Director | – | Mar 16, 2023 | 0 |
| Klopp John Michael | Chief Technical Officer | – | Mar 16, 2023 | 0 |
| Paul Bernard H | Chief People Officer | – | Mar 16, 2023 | 0 |
| Quartel Adrian W | Chief Medical Officer | – | Mar 16, 2023 | 0 |
| Hayden Tanya | Chief Operating Officer | – | Mar 16, 2023 | 0 |
| Seibt Matthew | Chief Commercial Officer | – | Jan 19, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 (view filing) | Nov 29 | 2 days | Schelling ChrisPresident & CEO | PPurchase | +819.7K | $1.22 | +$1.00M | +43.3%2.71M after | |
| Dec 1, 2022 (view filing) | Nov 29 | 2 days | Aselage SteveDirector | PPurchase | +409.8K | $1.22 | +$500.0K | +554.5%483.7K after | |
| Dec 13, 2021 (view filing) | Dec 9-10 | 4 days | Aselage SteveDirector | PPurchase | +10.0K | $2.06 | +$20.6K | +15.6%73.9K after | 2 lots |